Art

J-GLOBAL ID：201502202968551223   Reference number：15A0937455

持効性注射製剤の意義再考 経口薬と比較した抗精神病薬持効性注射剤(LAI)の再発予防効果

Author (2)： KISHIMOTO TAISHIRO (慶応大 医 精神・神経科) ,  KISHIMOTO TAISHIRO (Hofstra North Shore-LIJ医大)
Material： 精神科治療学  (Japanese Journal of Psychiatric Treatment)
Volume： 30  Issue： 7  Page： 931-937  Publication year： Jul. 19, 2015 
JST Material Number： X0617A  ISSN： 0912-1862  Document type： Article
Article type： 解説  Country of issue： Japan (JPN)  Language： JAPANESE (JA)

Thesaurus term： human(primates) ,...
Semi thesaurus term： ミラーイメージ試験 ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=15A0937455&from=J-GLOBAL&jstjournalNo=X0617A") }}

JST classification (2)： Drug therapy(=pharmacotherapy)for mental disorders  (GR04020D) ,  Clinical application of psychotropic drugs  (GW03110J)

Reference (10)：

• Alphs, L., Benson, C., Cheshire-Kinney, K. et al.: Real-World outcomes of paliperidone palmitate compared to daily oral antipsychotic therapy in schizophrenia : a randomized, open-label, review board-blinded 15-month study. J. Clin. Psychiatry, 2015. [Epub ahead of print]
• Fleischhacker, W.W., Arango, C., Arteel, P. et al. : Schizophrenia-time to commit to policy change. Schizophr. Bull., 40 (Suppl.3) ; S165-194, 2014.
• Ishigooka, J., Nakamura, J., Fujii, Y. et al. : ALPHA Study Group : Efficacy and safety of aripiprazole once-monthly in Asian patients with schizophrenia : a multicenter, randomized, double-blind, non-inferiority study versus oral aripiprazole. Schizophr. Res., 161 (2-3) ; 421-428, 2015.
• Jääskeläinen, E., Juola, P., Hirvonen, N. et al. : A systematic review and meta-analysis of recovery in schizophrenia. Schizophr. Bull., 39 ; 1296-1306, 2013.
• Kane, J.M., Kishimoto, T. and Correll, C.U. : Non-adherence to medication in patients with psychotic disorders : epidemiology, contributing factors and management strategies. World Psychiatry, 12 ; 216-226, 2013.

Terms in the title (6)： 持効性注射製剤 ,  経口薬 ,  抗精神病薬 ,  持効性注射剤 ,  LAI ,  再発予防効果